Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-11-10

Clinical Trial Update: Effect of the Addition of Dexmedetomidine to Bupivacaine During Supraclavicular Brachial Plexus Blockade [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing whether adding dexmedetomidine to bupivacaine improves outcomes for supraclavicular brachial plexus block in patients wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)
  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: TC Erciyes University | Conditions: Sequelae of Fracture of Forearm and Upper Arm | Phase 4 | Status: COMPLETED